# GEMINI-NSCLC: NSCLC Biomarker Study

> **NCT05236114** · — · RECRUITING · sponsor: **Tempus AI** · enrollment: 1200 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **OTHER:** Observation

## Key facts

- **NCT ID:** NCT05236114
- **Lead sponsor:** Tempus AI
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-22
- **Primary completion:** 2029-06
- **Final completion:** 2029-06
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05236114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05236114, "GEMINI-NSCLC: NSCLC Biomarker Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05236114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*